Pelvic exenteration: analysis of 296 patients
- PMID: 930972
- DOI: 10.1016/0002-9378(77)90521-x
Pelvic exenteration: analysis of 296 patients
Abstract
An analysis of 296 patients who had pelvic exenteration discloses a high risk of postoperative complications and death; however, the safety has been improved by technical modifications for urinary diversion and treatment of the denuded pelvic cavity. Recurrent cancer of the cervix or vagina was the main reason for the operation. Prognostic factors were sought to improve selection of patients who are able to withstand operation, tolerate postoperative complications, and remain free of cancer. The five-year survival rate for 296 patients with various types of cancer calculated by the Berkson-Gage method was 56.5 per cent after death from all causes were deducted, the rate was 42.1 per cent. The five-year survival rate for 196 patients with recurrent carcinoma of the cervix calculated by the Berkson-Gage method was 48.3 per cent; after deaths from all causes were deducted, the rate was 33.8 per cent.
Similar articles
-
Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.Int J Gynecol Cancer. 2014 Nov;24(9):1679-85. doi: 10.1097/IGC.0000000000000288. Int J Gynecol Cancer. 2014. PMID: 25254565
-
Exenterative operations: experience with 198 patients.Am J Obstet Gynecol. 1975 Apr 1;121(7):907-18. doi: 10.1016/0002-9378(75)90908-4. Am J Obstet Gynecol. 1975. PMID: 1115180
-
(Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.Gynecol Oncol. 2012 Nov;127(2):297-302. doi: 10.1016/j.ygyno.2012.07.120. Epub 2012 Aug 1. Gynecol Oncol. 2012. PMID: 22864112 Clinical Trial.
-
Pelvic exenteration.Cancer Invest. 1987;5(4):331-8. Cancer Invest. 1987. PMID: 3311312 Review.
-
[Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].Zhonghua Fu Chan Ke Za Zhi. 2014 Jun;49(6):460-5. Zhonghua Fu Chan Ke Za Zhi. 2014. PMID: 25169641 Review. Chinese.
Cited by
-
The impact of nutritional risk factors and sarcopenia on survival in patients treated with pelvic exenteration for recurrent gynaecological malignancy: a retrospective cohort study.Arch Gynecol Obstet. 2022 May;305(5):1343-1352. doi: 10.1007/s00404-021-06273-7. Epub 2021 Nov 3. Arch Gynecol Obstet. 2022. PMID: 34734326 Free PMC article.
-
Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.Gynecol Oncol. 2021 Nov;163(2):294-298. doi: 10.1016/j.ygyno.2021.08.033. Epub 2021 Sep 10. Gynecol Oncol. 2021. PMID: 34518053
-
Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.BMC Cancer. 2020 Nov 30;20(1):1169. doi: 10.1186/s12885-020-07672-w. BMC Cancer. 2020. PMID: 33256667 Free PMC article.
-
Perineal hernia repair using permanent suture and mesh: a video case presentation.Int Urogynecol J. 2019 Nov;30(11):1981-1983. doi: 10.1007/s00192-019-03956-3. Epub 2019 May 28. Int Urogynecol J. 2019. PMID: 31139857
-
Anterior perineal hernia after anterior exenteration.Asian J Urol. 2017 Oct;4(4):253-255. doi: 10.1016/j.ajur.2017.03.002. Epub 2017 Mar 14. Asian J Urol. 2017. PMID: 29387558 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
